Reverse drug distribution in Poland
Marek Stych
Institute of Law and Economics, Pedagogical University of CracowPoland
Orcid profileSearch for this author on
and Beata Pawlica
Faculty of Social Sciences, Institute of Political Sciences and Administration, Pedagogical University of CracowPoland
Orcid profileSearch for this author on
Oct 08, 2021
About this article
Published Online: Oct 08, 2021
Page range: 149 - 153
Received: Apr 20, 2021
Accepted: Aug 20, 2021
DOI: https://doi.org/10.2478/cipms-2021-0028
Keywords
© 2021 Marek Stych et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The trade and distribution of drugs or medicines (the two terms are used interchangeably in the paper) has been evolving throughout the history of European pharmacy. In order to ensure that EU citizens are safe, certain legislative measures had to be taken to prevent the illegal trade in drugs. The problem that affects the Polish pharmaceutical market is the illegal export of medicines. The article attempts to analyse the so-called reverse drug distribution, doing so by employing the dogmatic legal method. The paper ends with